3-Bromo-5-((trifluoromethyl)thio)pyridin-2-amine

Catalog No.: 
ACPKLD164
CAS No.: 
1383834-79-4
Molecular Formula: 
C6H4BrF3N2S
Molecular Weight: 
273.08
3-Bromo-5-((trifluoromethyl)thio)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$876.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-((trifluoromethyl)thio)pyridin-2-amine
IUPAC Name3-bromo-5-((trifluoromethyl)thio)pyridin-2-amine
Molecular FormulaC6H4BrF3N2S
Molecular Weight273.08
SMILESNC1=NC=C(SC(F)(F)F)C=C1Br
InChI KeyCQDQBTZSKFTHNJ-UHFFFAOYSA-N
Synonym2-Pyridinamine, 3-bromo-5-[(trifluoromethyl)thio]-
CAS No.1383834-79-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPKLD164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDGKT712 route compound structure diagram
    ACDGKT7123872-23-9In Stock
  2. Plus
  3. ACAFDO578 route compound structure diagram
    ACAFDO57835486-42-1In Stock
  4. Then
  5. ACPKLD164 route product structure diagram
    ACPKLD1641383834-79-4
Inquiry

2. ACPKLD164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDGKT712 route compound structure diagram
    ACDGKT7123872-23-9In Stock
  2. Plus
  3. ACQBDL840 route compound structure diagram
    ACQBDL84026163-03-1In Stock
  4. Then
  5. ACPKLD164 route product structure diagram
    ACPKLD1641383834-79-4
Inquiry

3. ACPKLD164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDGKT712 route compound structure diagram
    ACDGKT7123872-23-9In Stock
  2. Plus
  3. ACMNHK598 route compound structure diagram
    ACMNHK598869557-43-7In Stock
  4. Then
  5. ACPKLD164 route product structure diagram
    ACPKLD1641383834-79-4
Inquiry

Comments (0)